Related Experiment Videos
Measuring Safer Opioid Use in Hospitals: Development of Consensus-Based Safety and Quality Indicators - a modified
Abdullah Mutashar1, Martin L Canning1,2, Jodie Hillen1
1School of Pharmacy and Pharmaceutical Sciences, Faculty of Health, Medicine and Behavioural Sciences, The University of Queensland, Woolloongabba, Queensland, Australia.
Summary
Opioid harm in hospitals is a serious issue. This study developed 17 consensus-based safety and quality indicators (SQIs) for monitoring opioid use and improving patient safety.
Area of Science:
- Healthcare Quality Improvement
- Patient Safety
- Medication Safety
Background:
- Opioids contribute significantly to preventable medication-related harm in Australian hospitals, including deaths and adverse events.
- There is a critical need for effective systems to ensure safe opioid use and monitor performance.
- Proactive monitoring and system improvements are essential to mitigate opioid-related risks.
Purpose of the Study:
- To develop a consensus-based suite of opioid-related safety and quality indicators (SQIs).
- To ensure these SQIs are evidence-informed, important, and feasible for routine monitoring across health services.
- To establish a foundation for enhanced patient safety in opioid management.
Main Methods:
- A systematic literature search identified potential SQIs.
- A multidisciplinary clinical reference group (CRG) used a modified Delphi electronic survey method.
- Indicators were rated on importance and feasibility using a 9-point Likert scale, with consensus defined by specific criteria.
Main Results:
- Out of 34 initially considered indicators, 17 reached consensus for importance and feasibility.
- The process involved literature review, CRG input, and multi-round surveys with high response rates.
- A total of 17 opioid-related safety and quality indicators were finalized.
Conclusions:
- Consensus was achieved on 17 opioid-related safety and quality indicators.
- These indicators are deemed important and feasible for implementation by a multidisciplinary group.
- Adoption of these SQIs will facilitate monitoring, reporting, and improvement of opioid medication safety systems, enhancing patient care.
Related Concept Videos
01:26Pharmaceutical Poisoning: Potential Scenarios
Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
01:25Analgesia and Pain Management
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
01:25Drug Regulation
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
01:22Healthcare Associated Infections II: Preventive Measures
Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
01:15Opioid Analgesics: Synthetic and Semisynthetic Opioids
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
01:19Pharmacovigilance
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...